Travere Therapeutics to Report First Quarter 2021 Financial Results
April 26 2021 - 4:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will
report first quarter 2021 financial results on Thursday, May 6,
2021 after the close of the U.S. financial markets. The Company
will host a conference call and webcast to discuss the financial
results and provide a general business update at 4:30 p.m. ET.
Conference Call Information
Date:
|
Thursday, May 6, 2021 |
Time: |
4:30 p.m. ET |
Dial-in numbers: |
+1 (800) 773-2954 (U.S.) or +1 (847) 413-3731
(International) |
Confirmation code: |
50155370 |
Live webcast: |
Travere.com in the “Events & Presentations” section of the
“Investors” page |
A replay of the call will be available from 7:30 p.m. ET, May 6,
2021 to 7:30 p.m. ET, May 13, 2021. The replay number is +1 (855)
859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation
code 50155370.
About Travere Therapeutics
At Travere Therapeutics we are in rare for life.
We are a biopharmaceutical company that comes together every day to
help patients, families and caregivers of all backgrounds as they
navigate life with a rare disease. On this path, we know the need
for treatment options is urgent – that is why our global team works
with the rare disease community to identify, develop and deliver
life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com
Contact:Chris Cline,
CFA
Senior Vice
President, Investor Relations & Corporate
Communications888-969-7879 IR@travere.com
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Apr 2023 to Apr 2024